0001829126-22-014208.txt : 20220708 0001829126-22-014208.hdr.sgml : 20220708 20220708180019 ACCESSION NUMBER: 0001829126-22-014208 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220706 FILED AS OF DATE: 20220708 DATE AS OF CHANGE: 20220708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Activist Investing LLC CENTRAL INDEX KEY: 0001817604 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 221075468 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646 768 8417 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. CITY: NEW YORK STATE: NY ZIP: 10036 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lazar David E. CENTRAL INDEX KEY: 0001932843 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 221075469 MAIL ADDRESS: STREET 1: VILLA 1, 14-43RD STREET STREET 2: JUMEIRAH 2 CITY: DUBAI STATE: C0 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 3 1 ownership.xml 3 X0206 3 2022-07-06 0 0000910267 TITAN PHARMACEUTICALS INC TTNP 0001932843 Lazar David E. VILLA 1, 14-43RD STREET JUMEIRAH 2 DUBAI C0 00000 UNITED ARAB EMIRATES 0 0 1 0 0001817604 Activist Investing LLC 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036 0 0 0 1 Member of 10% owner group Common Stock, par value $0.001 1421133 D Common Stock, par value $0.001 43145 I By Activist Investing LLC This Form 3 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons"). Securities of Titan Pharmaceuticals, Inc. (the "Issuer") beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/ David E. Lazar 2022-07-08 Activist Investing LLC, By: /s/ David E. Lazar, Chief Executive Officer 2022-07-08